Augurex logo and ARUP Laboratories logo

ARUP Laboratories and Augurex Life Sciences Corp. are partnering to incorporate a 14-3-3η test that will aid in the early detection and management of rheumatoid arthritis.

October 21, 2024

Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis

ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis.

Digitally colorized transmission electron microscopic image of avian influenza A.

Digitally colorized transmission electron microscopic image of avian influenza A (H5N1) virus particles (in gold), grown in Madin-Darby canine kidney (MDCK) epithelial cells (in green).

September 13, 2024

ARUP Awarded CDC Contract for Bird Flu Test Development

ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.

Sherrie Perkins

The research grant is named in honor of retired ARUP CEO Sherrie Perkins, MD, PhD, whose leadership laid the groundwork for ARUP’s increased focus on innovation.

July 30, 2024

New ARUP Laboratories’ Grant Will Fund Innovative Research to Advance Laboratory Medicine

The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care.

A caduceus balancing scales

ARUP Laboratories has filed a declaration supporting a lawsuit against the FDA brought by the American Clinical Laboratory Association.

May 30, 2024

ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-

ARUP’s declaration amplifies the lawsuit’s claims that the FDA does not have legal authority over laboratory testing services and that regulating these services is unreasonable.

testing equipment

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

April 29, 2024

ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.

ELLKay logo

The connectivity platform LKOrbit streamlines test ordering, reporting, and billing for laboratory outreach operations.

April 24, 2024

ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations

A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.